215 related articles for article (PubMed ID: 26466521)
1. Honokiol Inhibits Constitutive and Inducible STAT3 Signaling via PU.1-Induced SHP1 Expression in Acute Myeloid Leukemia Cells.
Bi L; Yu Z; Wu J; Yu K; Hong G; Lu Z; Gao S
Tohoku J Exp Med; 2015 Nov; 237(3):163-72. PubMed ID: 26466521
[TBL] [Abstract][Full Text] [Related]
2. Honokiol inhibits signal transducer and activator of transcription-3 signaling, proliferation, and survival of hepatocellular carcinoma cells via the protein tyrosine phosphatase SHP-1.
Rajendran P; Li F; Shanmugam MK; Vali S; Abbasi T; Kapoor S; Ahn KS; Kumar AP; Sethi G
J Cell Physiol; 2012 May; 227(5):2184-95. PubMed ID: 21792937
[TBL] [Abstract][Full Text] [Related]
3. Honokiol induces proteasomal degradation of AML1-ETO oncoprotein via increasing ubiquitin conjugase UbcH8 expression in leukemia.
Zhou B; Li H; Xing C; Ye H; Feng J; Wu J; Lu Z; Fang J; Gao S
Biochem Pharmacol; 2017 Mar; 128():12-25. PubMed ID: 28043811
[TBL] [Abstract][Full Text] [Related]
4. Honokiol inhibits epithelial-mesenchymal transition in breast cancer cells by targeting signal transducer and activator of transcription 3/Zeb1/E-cadherin axis.
Avtanski DB; Nagalingam A; Bonner MY; Arbiser JL; Saxena NK; Sharma D
Mol Oncol; 2014 May; 8(3):565-80. PubMed ID: 24508063
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of SHP1 and up-regulation of negative regulators of JAK/STAT signaling in HTLV-1 transformed cell lines and freshly transformed human peripheral blood CD4+ T-cells.
Cheng J; Zhang D; Zhou C; Marasco WA
Leuk Res; 2004 Jan; 28(1):71-82. PubMed ID: 14630083
[TBL] [Abstract][Full Text] [Related]
6. Honokiol Decreases Lung Cancer Metastasis through Inhibition of the STAT3 Signaling Pathway.
Pan J; Lee Y; Zhang Q; Xiong D; Wan TC; Wang Y; You M
Cancer Prev Res (Phila); 2017 Feb; 10(2):133-141. PubMed ID: 27849557
[TBL] [Abstract][Full Text] [Related]
7. Anticancer activity of dietary xanthone α-mangostin against hepatocellular carcinoma by inhibition of STAT3 signaling via stabilization of SHP1.
Zhang H; Tan YP; Zhao L; Wang L; Fu NJ; Zheng SP; Shen XF
Cell Death Dis; 2020 Jan; 11(1):63. PubMed ID: 31980595
[TBL] [Abstract][Full Text] [Related]
8. Antitumorigenic effect of plumbagin by induction of SH2-containing protein tyrosine phosphatase 1 in human gastric cancer cells.
Joo MK; Park JJ; Kim SH; Yoo HS; Lee BJ; Chun HJ; Lee SW; Bak YT
Int J Oncol; 2015; 46(6):2380-8. PubMed ID: 25815436
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of STAT3 and activation of MAPK are involved in the induction of apoptosis by HNK in glioblastoma cell line U87.
Zhang Y; Ren X; Shi M; Jiang Z; Wang H; Su Q; Liu Q; Li G; Jiang G
Oncol Rep; 2014 Nov; 32(5):2038-46. PubMed ID: 25175884
[TBL] [Abstract][Full Text] [Related]
10. Calpain/SHP-1 interaction by honokiol dampening peritoneal dissemination of gastric cancer in nu/nu mice.
Liu SH; Wang KB; Lan KH; Lee WJ; Pan HC; Wu SM; Peng YC; Chen YC; Shen CC; Cheng HC; Liao KK; Sheu ML
PLoS One; 2012; 7(8):e43711. PubMed ID: 22937084
[TBL] [Abstract][Full Text] [Related]
11. Morin inhibits STAT3 tyrosine 705 phosphorylation in tumor cells through activation of protein tyrosine phosphatase SHP1.
Gupta SC; Phromnoi K; Aggarwal BB
Biochem Pharmacol; 2013 Apr; 85(7):898-912. PubMed ID: 23279849
[TBL] [Abstract][Full Text] [Related]
12. Restoration of shp1 expression by 5-AZA-2'-deoxycytidine is associated with downregulation of JAK3/STAT3 signaling in ALK-positive anaplastic large cell lymphoma.
Han Y; Amin HM; Frantz C; Franko B; Lee J; Lin Q; Lai R
Leukemia; 2006 Sep; 20(9):1602-9. PubMed ID: 16871283
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of Notch-1 expression decreases PU.1-mediated myeloid differentiation signaling in acute myeloid leukemia.
Chen PM; Yen CC; Wang WS; Lin YJ; Chu CJ; Chiou TJ; Liu JH; Yang MH
Int J Oncol; 2008 Jun; 32(6):1335-41. PubMed ID: 18497996
[TBL] [Abstract][Full Text] [Related]
14. Honokiol induces cell cycle arrest and apoptosis via inhibiting class I histone deacetylases in acute myeloid leukemia.
Li HY; Ye HG; Chen CQ; Yin LH; Wu JB; He LC; Gao SM
J Cell Biochem; 2015 Feb; 116(2):287-98. PubMed ID: 25187418
[TBL] [Abstract][Full Text] [Related]
15. SHP1 and SHP2 inhibition enhances the pro-differentiative effect of phorbol esters: an alternative approach against acute myeloid leukemia.
Pérez-Fernández A; López-Ruano G; Prieto-Bermejo R; Ijurko C; Díez-Campelo M; Sánchez-Guijo F; Hernández-Hernández Á
J Exp Clin Cancer Res; 2019 Feb; 38(1):80. PubMed ID: 30764849
[TBL] [Abstract][Full Text] [Related]
16. Promoter methylation attenuates SHP1 expression and function in patients with primary central nervous system lymphoma.
Liu J; Wang Y; Sun X; Ji N; Sun S; Wang Y; Liu F; Cui Q; Wang C; Liu Y
Oncol Rep; 2017 Feb; 37(2):887-894. PubMed ID: 27959415
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic regulation and anti-tumorigenic effects of SH2-containing protein tyrosine phosphatase 1 (SHP1) in human gastric cancer cells.
Joo MK; Park JJ; Yoo HS; Lee BJ; Chun HJ; Lee SW; Bak YT
Tumour Biol; 2016 Apr; 37(4):4603-12. PubMed ID: 26508024
[TBL] [Abstract][Full Text] [Related]
18. Arctigenin enhances chemosensitivity of cancer cells to cisplatin through inhibition of the STAT3 signaling pathway.
Yao X; Zhu F; Zhao Z; Liu C; Luo L; Yin Z
J Cell Biochem; 2011 Oct; 112(10):2837-49. PubMed ID: 21608020
[TBL] [Abstract][Full Text] [Related]
19. Honokiol abrogates leptin-induced tumor progression by inhibiting Wnt1-MTA1-β-catenin signaling axis in a microRNA-34a dependent manner.
Avtanski DB; Nagalingam A; Kuppusamy P; Bonner MY; Arbiser JL; Saxena NK; Sharma D
Oncotarget; 2015 Jun; 6(18):16396-410. PubMed ID: 26036628
[TBL] [Abstract][Full Text] [Related]
20. Honokiol: A polyphenol neolignan ameliorates pulmonary fibrosis by inhibiting TGF-β/Smad signaling, matrix proteins and IL-6/CD44/STAT3 axis both in vitro and in vivo.
Pulivendala G; Bale S; Godugu C
Toxicol Appl Pharmacol; 2020 Mar; 391():114913. PubMed ID: 32032644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]